Surge In Genetic Disorders Propels Growth Of Genetic Testing Market: Critical Driver Shaping the Global Genetic Testing Market in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Genetic Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The genetic testing sector has experienced substantial expansion recently, projected to increase its valuation from $19.1 billion in the year 2024 to $20.84 billion by 2025, reflecting a compound annual growth rate of 9.1%. This upward trajectory observed during the historical span is attributable to several factors, including escalating spending within the healthcare domain, a growing incidence of cancer cases, heightened consumer requirements for tailored medical treatments, and the appearance of new infectious ailments.

Genetic Testing Market Size Forecast: What's the Projected Valuation by 2029?
Projections indicate that the genetic testing market is poised for substantial expansion moving forward, reaching an assessed value of $29.87 billion by the year 2029, fueled by a consistent compound annual growth rate (CAGR) of 9.4%; this upward trajectory is underpinned by escalating governmental backing, a greater incidence of hereditary conditions, the aging global demographic, and the broader rise in chronic ailment frequency; key developments shaping this timeframe involve the debut of novel initiatives like genetic counseling and informatics curricula designed to cultivate future testing expertise, alongside continuous technological improvements and the introduction of direct-to-consumer genetic screening options.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

What Are the Drivers Transforming the Genetic Testing Market?
Increased incidence of conditions related to genetics is anticipated to fuel the expansion of the market for genetic testing in the future. These genetic ailments encompass illnesses manifesting at birth alongside those that emerge progressively; genetic screening offers aid in diagnosing such hereditary problems and furnishes data concerning cancer susceptibility. For illustration, data from a 2024 World Health Organization report, originating from the Switzerland-headquartered Intergovernmental body, indicates that genetic conditions and birth defects impact between two and five percent of newborns, constitute thirty percent of pediatric admissions to hospitals, and are responsible for approximately fifty percent of mortality among children in developed nations, thus highlighting how escalating genetic disorder rates are stimulating the genetic testing sector.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6729&type=smp

What Long-Term Trends Will Define the Future of the Genetic Testing Market?
A notable movement within the genetic testing industry involves tests sold directly to consumers. These direct-to-consumer (DTC) deoxyribonucleic acid or DNA assessments, often termed at-home DNA tests, allow individuals to collect samples within their residence and submit them for analysis to ascertain their inherited susceptibility to particular ailments. Such self-administered genetic analysis scrutinizes the individual's DNA profile, capable of pinpointing variations in genes that elevate the likelihood of contracting certain health issues. Illustratively, DNALabs, an organization located in India and focused on providing genetic testing services to revolutionize tailored medical care, launched its At-Home Genetic Testing Solutions during 2022. With a straightforward cheek swab administered via their at-home collection kit, DNALabs empowers clients, ranging from individuals proactively managing their own wellness to medical practitioners aiming to tailor optimal care plans for those under their supervision, to make determinations based on informed understanding.

Which Segments in the Genetic Testing Market Offer the Most Profit Potential?
The genetic testingmarket covered in this report is segmented -

1) By Type: Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomics Testing, Nutrigenomic Testing, Other Types
2) By Technology: Cytogenetic Testing, Biochemical Testing, Molecular Testing
3) By Application: Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Other Applications
4) By End User: Hospitals And Clinics, Diagnostic Laboratories And Centres, Other End Users

Subsegments:
1) By Predictive Testing: Genetic Risk Assessment; Family History-Based Testing
2) By Carrier Testing: Single Gene Carrier Testing; Expanded Carrier Screening
3) By Prenatal And Newborn Testing: Non-Invasive Prenatal Testing (NIPT); Newborn Screening Tests
4) By Diagnostic Testing: Confirmatory Genetic Testing; Clinical Diagnostic Testing
5) By Pharmacogenomics Testing: Drug Response Testing; Adverse Drug Reaction Testing
6) By Nutrigenomic Testing: Dietary Response Testing; Metabolism Testing
7) By Other Types: Ancestry Testing; Whole Genome Sequencing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6729&type=smp

Which Firms Dominate the Genetic Testing Market by Market Share and Revenue in 2025?
Major companies operating in the genetic testing market include Myriad Genetics Inc, Illumina Inc, Abbott Laboratories, Eurofins Scientific, Danaher Corporation, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Qiagen NV, Thermo Fisher Scientific Inc., BioRad Laboratories Inc., BGI, Berry Genomics Co. ltd, Daan Gene Co. Ltd, Annoroad Gene Technology Co. Ltd, WuXi PharmaTech, Igenomix, Circle DNA, Centogene, Curetis, Cytena, Probably Genetic, Genome Biologics, WuXi NextCODE, Genomtec, Testgene, Evogen Lab, Phosphorus, Helix, Sequencing, 10x Genomics, Quantgene, Virica Biotech, DNALabs, Deep Genomics, SGS Mexico, Hologic Inc, 23andMe Inc, Middle East Testing Services L.L.C, Molecular Biology & Genetics Laboratory, Freiburg Medical Laboratory Middle East, IVI MIDDLE EAST FERTILITY CLINIC, Bio Certica

Which Regions Offer the Highest Growth Potential in the Genetic Testing Market?
North America was the largest region in the genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6729

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.